Cephalalgia : an international journal of headache
-
Comparative Study
Comparison of healthcare resource utilization and costs among patients with migraine with potentially adequate and insufficient triptan response.
Triptans are the most commonly prescribed acute treatments for migraine; however, not all triptan users experience adequate response. Information on real-world resource use and costs associated with triptan insufficient response are limited. ⋯ In a US commercial health plan, almost one-third of new triptan users were potential triptan insufficient responders and the majority filled opioid prescriptions. Potential triptan insufficient responder patients had significantly higher all-cause and migraine-related healthcare utilization and costs than triptan-only continuers.